logo
Select company
Select metric
$ -643KNet Cash Flow - Change in Cash & Cash Equivalents
VS
Market
44
Sector
51
Industry
52
History
57
$ 5.17Close
$ 2.82 - $ 16.95 52-Week Range
Ticker Information

Ticker

EKSO

Company Name

EKSO BIONICS HOLDINGS INC

Sector

Healthcare

Industry

Medical Instruments & Supplies

Exchange

NASDAQ

EKSO BIONICS HOLDINGS INC - Net Cash Flow - Change in Cash & Cash Equivalents Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

EKSO - CF - Chg. Cash Historical data
DateNet Cash Flow - Change in Cash & Cash Equivalents
6/30/2025$ -643K
3/31/2025$ -745K
12/31/2024$ -2.15M
9/30/2024$ -1.65M
6/30/2024$ -7.42M
3/31/2024$ -7.48M
12/31/2023$ -11.89M
9/30/2023$ -19.24M
6/30/2023$ -18.61M
3/31/2023$ -19.9M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • EKSO BIONICS HOLDINGS INC's latest trailing twelve months (TTM) CF - Chg. Cash stands at $ 6.49M.
  • Over the past 5 years, EKSO BIONICS HOLDINGS INC's average CF - Chg. Cash has been $ -631.25K.
  • The median CF - Chg. Cash for EKSO BIONICS HOLDINGS INC during this period was $ -4.78M
  • EKSO BIONICS HOLDINGS INC reached its highest CF - Chg. Cash over the past 5 years at $ 41.02M.
  • The lowest CF - Chg. Cash recorded by EKSO BIONICS HOLDINGS INC in the same timeframe $ -19.9M

EKSO BIONICS HOLDINGS INC's CF - Chg. Cash vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Chg. Cash Benchmarks
CompanyCF - Chg. Cash
VSEE : VSEE HEALTH INC $ -814.38KCARM : CARISMA THERAPEUTICS INC $ -38.36MLUCY : INNOVATIVE EYEWEAR INC $ 1.73MCSCIF : COSCIENS BIOPHARMA INC $ -18.47MEVOK : EVOKE PHARMA INC $ 2.88MNXGL : NEXGEL INC $ -344KPOAI : PREDICTIVE ONCOLOGY INC $ -4.83MBNGO : BIONANO GENOMICS INC $ -18.27MSNOA : SONOMA PHARMACEUTICALS INC $ 1.02MMSPR : MSP RECOVERY INC $ -3.12M

Definition of Net Cash Flow - Change in Cash & Cash Equivalents

[Cash Flow Statement] Represents the amount of increase (decrease) in cash and cash equivalents. Includes cash from operations [NCFO], investing [NCFI] and financing [NCFF], adjusted for the effect of exchange rate changes on cash [NCFX]

EKSO - Net Cash Flow - Change in Cash & Cash Equivalents, Last 5 years

$ -19.9M

Minimum

Mar 31, 2023

$ 41.02M

Maximum

Mar 31, 2021

$ -631.25K

Average

$ -4.78M

Median

CF - Chg. Cash Benchmark Analysis

The chart above depicts the distribution of CF - Chg. Cash for companies in the Total Stock Market. The average CF - Chg. Cash of the companies is $ 1.17M with a standard deviation of $ 44.93M.
The following table provides additional summary stats:
CF - Chg. Cash in the Market:
filtered constituents3.34K
min$ -136.09M
max$ 137.58M
average$ 1.17M
median$ 115.89K
std$ 44.93M